Your session is about to expire
← Back to Search
Coaching and Weight Loss for patients with dyspnea for Lung Disease
N/A
Waitlist Available
Led By Roberto P Benzo
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a lifestyle intervention to see if it can help obese people with chronic lung disease and breathlessness.
Eligible Conditions
- Lung Disease
- Chronic Obstructive Pulmonary Disease
- Emphysema
- CPFE Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Breathlessness
Secondary study objectives
Body Mass Index using InBody 770 Scale
Daily Physical Activity
Daily Sedentary Time
+10 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Multicomponent Intervention for weight lossExperimental Treatment1 Intervention
12-week intervention that consists of Weight Watcher on-line program, Garmin Fitness Tracker, blue-tooth scale, and telephonic health coaching.
Group II: Wait-list ControlActive Control1 Intervention
The participant will receive usual care for 12 weeks and then will compassionately be offered the active intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Coaching and Weight Loss for patients with dyspnea
2019
N/A
~30
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,351 Previous Clinical Trials
3,060,929 Total Patients Enrolled
Roberto P BenzoPrincipal InvestigatorMayo Clinic
8 Previous Clinical Trials
592 Total Patients Enrolled